Cytomegalovirus (CMV) reactivation is associated with a lower incidence of relapse after allogeneic stem cell transplantation (SCT) for chronic myelogenous leukemia (CML)

Preemptive therapy at CMV reactivation has diminished post-transplant CMV mortality. Furthermore, recent studies suggest a favorable “virus-versus-leukemia” effect from reactivating CMV, reducing relapse of acute myeloid leukemia (AML) after SCT. We studied the relationship of CMV reactivation with...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Bone Marrow Transplant
Glavni autori: Ito, Sawa, Pophali, Priyanka, Colin, O. Wu, Koklanaris, Eleftheria K., Superata, Jeanine, Fahle, Gary A., Childs, Richard, Battiwalla, Minoo, Barrett, A. John
Format: Artigo
Jezik:Inglês
Izdano: 2013
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5274543/
https://ncbi.nlm.nih.gov/pubmed/23562969
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2013.49
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items